Valuation: Avantor, Inc.

Market Cap 11.02B 9.82B 9.1B 8.27B 15.52B 1,045B 15.78B 109B 42.91B 546B 41.34B 40.47B 1,745B P/E 2026 *
47.2x
P/E 2027 * 34.9x
Enterprise Value 14.05B 12.52B 11.6B 10.55B 19.79B 1,332B 20.12B 139B 54.71B 696B 52.71B 51.6B 2,225B EV / Sales 2026 *
2.13x
EV / Sales 2027 * 1.98x
Free-Float
95.47%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 2025-08-17
Director of Finance/CFO 57 2026-09-20
Chief Operating Officer - 2025-11-09
Director TitleAgeSince
Director/Board Member 60 2020-04-21
Chairman 69 2025-12-31
Director/Board Member 62 2021-09-30
Date Insider Type Main position Quantity % Market Cap. Importance
9/21/26 Free

Chief Financial Officer

188,320 0.0276%
8/18/26 Tax

Chief Executive Officer

-29,803 0.0044%
8/14/26 Tax

Head of Human Resources

-181 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.79%+5.16% - - 11.02B
-0.79%+2.20%-19.04%+9.03% 180B
-2.09%+0.91%-3.14%+28.22% 114B
+1.11%+5.43%-20.43%+11.00% 114B
+0.36%+4.31%-51.39%-6.41% 78.39B
-0.27%+4.60%+4.72%+79.05% 64.88B
+1.60%+2.67%+15.08%+77.83% 54.02B
-0.53%+0.98%+0.87%-25.92% 51.96B
-0.81%+6.08%-12.53%+30.57% 43.79B
-0.07%+0.07%+29.10%-0.07% 32.45B
Average -0.23%+3.18%-6.31%+22.59% 74.44B
Weighted average by Cap. -0.31%+3.00%-11.71%+20.33%

Financials

2026 *2027 *
Net sales 6.59B 5.88B 5.45B 4.95B 9.29B 625B 9.44B 65.31B 25.68B 327B 24.74B 24.22B 1,045B 6.74B 6.01B 5.57B 5.06B 9.5B 639B 9.66B 66.8B 26.27B 334B 25.3B 24.77B 1,068B
Net income 225M 201M 186M 169M 317M 21.37B 323M 2.23B 878M 11.17B 846M 828M 35.7B 311M 277M 257M 234M 438M 29.51B 446M 3.08B 1.21B 15.42B 1.17B 1.14B 49.3B
Net Debt 3.03B 2.7B 2.5B 2.28B 4.27B 287B 4.34B 30.01B 11.8B 150B 11.37B 11.13B 480B 2.36B 2.1B 1.95B 1.77B 3.32B 224B 3.38B 23.35B 9.18B 117B 8.85B 8.66B 373B
Projected Income Statement - Annual - Avantor, Inc.
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company's segments include Bioscience & Medtech Products and VWR Distribution & Services. Through these segments, it provides materials and consumables, equipment and instrumentation and services and specialty procurement to customers in biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and others.
Employees
13,500
Date Price Change
26-10-19 US$16.29 -0.79%
26-10-16 US$16.42 +2.05%
26-10-15 US$16.09 +2.48%
26-10-14 US$15.70 +0.96%
26-10-13 US$15.55 +0.39%
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Avantor, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
16.29USD
Average target price
15.46USD
Spread / Average Target
-5.07%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Avantor, Inc.
  1. Stock Market
  2. Stocks
  3. AVTR Stock